Literature DB >> 24203926

AIDS-lymphoma (ARL): one more step along the way.

Alexandra M Levine1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24203926      PMCID： PMC3821721          DOI： 10.1182/blood-2013-09-526350

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  10 in total

1.  Chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma in combination with highly active antiretroviral therapy.

Authors:  L Ratner; J Lee; S Tang; D Redden; F Hamzeh; B Herndier; D Scadden; L Kaplan; R Ambinder; A Levine; W Harrington; L Grochow; C Flexner; B Tan; D Straus
Journal:  J Clin Oncol       Date:  2001-04-15       Impact factor: 44.544

2.  AIDS-related non-Hodgkin lymphoma: final analysis of 485 patients treated with risk-adapted intensive chemotherapy.

Authors:  Nicolas Mounier; Michele Spina; Jean Gabarre; Martine Raphael; Giuliano Rizzardini; Jean-Baptiste Golfier; Emanuela Vaccher; Antonino Carbone; Bertrand Coiffier; Guido Chichino; Andre Bosly; Umberto Tirelli; Christian Gisselbrecht
Journal:  Blood       Date:  2006-01-12       Impact factor: 22.113

3.  CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.

Authors:  Bertrand Coiffier; Eric Lepage; Josette Briere; Raoul Herbrecht; Hervé Tilly; Reda Bouabdallah; Pierre Morel; Eric Van Den Neste; Gilles Salles; Philippe Gaulard; Felix Reyes; Pierre Lederlin; Christian Gisselbrecht
Journal:  N Engl J Med       Date:  2002-01-24       Impact factor: 91.245

Review 4.  Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients.

Authors:  Stefan K Barta; Xiaonan Xue; Dan Wang; Roni Tamari; Jeannette Y Lee; Nicolas Mounier; Lawrence D Kaplan; Josep-Maria Ribera; Michele Spina; Umberto Tirelli; Rudolf Weiss; Lionel Galicier; Francois Boue; Wyndham H Wilson; Christoph Wyen; Albert Oriol; José-Tomás Navarro; Kieron Dunleavy; Richard F Little; Lee Ratner; Olga Garcia; Mireia Morgades; Scot C Remick; Ariela Noy; Joseph A Sparano
Journal:  Blood       Date:  2013-09-06       Impact factor: 22.113

5.  Pegylated liposomal doxorubicin, rituximab, cyclophosphamide, vincristine, and prednisone in AIDS-related lymphoma: AIDS Malignancy Consortium Study 047.

Authors:  Alexandra M Levine; Ariela Noy; Jeannette Y Lee; Wayne Tam; Juan Carlos Ramos; David H Henry; Samir Parekh; Erin G Reid; Ronald Mitsuyasu; Timothy Cooley; Bruce J Dezube; Lee Ratner; Ethel Cesarman; Anil Tulpule
Journal:  J Clin Oncol       Date:  2012-11-19       Impact factor: 44.544

6.  Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma.

Authors:  Joseph A Sparano; Jeannette Y Lee; Lawrence D Kaplan; Alexandra M Levine; Juan Carlos Ramos; Richard F Ambinder; William Wachsman; David Aboulafia; Ariela Noy; David H Henry; Jamie Von Roenn; Bruce J Dezube; Scot C Remick; Manisha H Shah; Lawrence Leichman; Lee Ratner; Ethel Cesarman; Amy Chadburn; Ronald Mitsuyasu
Journal:  Blood       Date:  2009-12-18       Impact factor: 22.113

7.  Low-dose chemotherapy with central nervous system prophylaxis and zidovudine maintenance in AIDS-related lymphoma. A prospective multi-institutional trial.

Authors:  A M Levine; J C Wernz; L Kaplan; N Rodman; P Cohen; C Metroka; J M Bennett; M U Rarick; C Walsh; J Kahn
Journal:  JAMA       Date:  1991-07-03       Impact factor: 56.272

8.  Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.

Authors:  F J Palella; K M Delaney; A C Moorman; M O Loveless; J Fuhrer; G A Satten; D J Aschman; S D Holmberg
Journal:  N Engl J Med       Date:  1998-03-26       Impact factor: 91.245

9.  Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010.

Authors:  Lawrence D Kaplan; Jeannette Y Lee; Richard F Ambinder; Joseph A Sparano; Ethel Cesarman; Amy Chadburn; Alexandra M Levine; David T Scadden
Journal:  Blood       Date:  2005-05-24       Impact factor: 22.113

10.  Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology.

Authors:  Richard F Little; Stefania Pittaluga; Nicole Grant; Seth M Steinberg; Mark F Kavlick; Hiroaki Mitsuya; Genoveffa Franchini; Martin Gutierrez; Mark Raffeld; Elaine S Jaffe; Gene Shearer; Robert Yarchoan; Wyndham H Wilson
Journal:  Blood       Date:  2003-02-27       Impact factor: 22.113
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.